Sclerosis multiplex (SM): vizsgálatok itt: Mexikó

In Mexikó 6 Also abroad 506

6 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
Where
Culiacán, Mexico City
Életkor
10 év to 17 év
People
12 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07161258 · EU 2024-519800-28-00
3. fázisTaking people
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Where
Mexico City
Életkor
40 év to 70 év
People
400 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06846281 · EU 2023-509275-17-00
3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Where
Benito Juárez, Chihuahua City, Mexico City, San Luis Potosí City
Életkor
18 év to 65 év
People
1275 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07225504
3. fázisTaking people
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Where
Mexico City
Életkor
10 év to 17 év
People
194 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06408259 · EU 2022-501332-42-00
No phaseCsak meghívásos
Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
Where
Monterrey
Életkor
4 év to 80 év
People
36
Run by
Healing Hope International
See details and how to joinNCT07521384
2. fázisCsak meghívásos
Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration
Where
Mexico City
Életkor
18 év to 65 év
People
80
Run by
Universidad Nacional Autonoma de Mexico
See details and how to joinNCT06223074